GR-1 and RC-14 have 90+ published studies over 25+ years for women's vaginal health. Clinically proven to reduce UTIs, yeast infections, and BV recurrence. No other women's probiotic has even 10% of this evidence base. The gold standard.
L. rhamnosus GR-1 and L. reuteri RC-14 are the two most clinically studied strains for women's vaginal and urinary health, with 25+ years of published research. 5 Billion CFU each is the exact dose used in clinical trials. This is evidence-based women's probiotic health at its finest. Simple, targeted, proven.
of 10000000000CFU
See exactly how this fits your health profile. What works for you, what doesn't, and whether you're getting your money's worth.
Unlock with ProCheck your full stack for interactions, redundancies, and gaps. Takes 30 seconds.